Synthese und Selbstorganisation von Perylendiimid-Oligonucleotid-Konjugaten

Im Rahmen dieser Arbeit wurde eine Methode entwickelt, Perylendiimidfarbstoffe mit Oligonucleotiden in der Lösung zu verknüpfen. Das Ziel der Arbeit war die nicht-kovalente Synthese von Perylendiimid-DNA- und Protein- supramolekularen Strukturen. Dabei werden die molekularen Erkennungseigenschaften von DNA und Proteinen zunutze gemacht. Insgesamt drei Themenbereiche wurden dabei betrachtet: 1. Synthese und Hybridisierung von symmetrischen und asymmetrischen Perylendiimid-bis(oligonucleotid)-konjugaten für die Bildung supramolekularer Strukturen, 2. Erzeugung von Oberflächenstrukturen auf der Basis von Streptavidin-Perylendiimid-Komplexen, 3. Synthese wasserlöslicher Rylenfarbstoffe für Anwendungen in biologischen Systemen. Zur Synthese und Hybridisierung von Perylendiimid-Oligonucleotid-Konjugaten wurde eine neue Idee verfolgt und erfolgreich realisiert. Dabei handelt es sich um die Synthese von Perylendiimid-DNA-Polymeren durch nicht-kovalente Bindungen. Die Basis des entwickelten Konzepts ist die Ausnutzung der Erkennungseigenschaften der DNA, um Perylendiimidmoleküle in eine lineare Makrostruktur zu organisieren, was sonst nur durch komplizierte chemische Polymersynthese zugänglich wäre. Die Selbstorganisation von zwei komplementären Perylendiimid-bis(oligonucleotid)-konjugaten (PODN1 und PODN2), die an der 5`-Position verknüpft sind, führte zu einem linearen Perylendiimid-DNA-Polymer in der Form von …ABABABAB…., das mit Hilfe von Gelelektrophorese charakterisiert wurde. Eindrucksvoll war auch die erfolgreiche Kopplung des hydrophoben Perylendiimids mit zwei unterschiedlichen Oligonucleotidsequenzen in der Lösung, um asymmetrische Perylendiimid-bis(oligonucleotid)-konjugate zu synthetisieren. Mit solchen asymmetrischen Konjugaten konnte die programmierbare Selbstorganisation der Perylendiimid-Oligonucleotide zu einer definierten Polymerstruktur realisiert werden. Die Synthese von PDI-(biotin)2 wurde vorgestellt. Durch die spezifische Erkennungseigenschaft zwischen Biotin und Streptavidin ist es möglich, eine Oberflächenstruktur zu bilden. Die Immobilisierungsexperimente zeigten, dass das PDI (biotin)2 Streptavidin erkennen und binden kann. Dabei konnte eine multischichtige Nanostruktur (5 Doppelschichten) auf einer Goldoberfläche.

Ceramic membranes for separation of proteins and DNA by in situ growth of alumina nanofibres with a nanomesh of metal oxide nanofibres

Ceramic membranes were fabricated by in situ synthesis of alumina nanofibres in the pores of an alumina support as a separation layer, and exhibited a high permeation selectivity for bovine serum albumin relative to bovine hemoglobin (over 60 times) and can effectively retain DNA molecules at high fluxes.

Synchronous fluorescence and UV–vis spectroscopic studies of interactions between the tetracycline antibiotic, aluminium ions and DNA with the aid of the Methylene Blue dye probe

Synchronous fluorescence spectroscopy (SFS) was applied for the investigation of interactions of the antibiotic, tetracycline (TC), with DNA in the presence of aluminium ions (Al3+). The study was facilitated by the use of the Methylene Blue (MB) dye probe, and the interpretation of the spectral data with the aid of the chemometrics method, parallel factor analysis (PARAFAC). Three-way synchronous fluorescence analysis extracted the important optimum constant wavelength differences, Δλ, and showed that for the TC–Al3+–DNA, TC–Al3+ and MB dye systems, the associated Δλ values were different (Δλ = 80, 75 and 30 nm, respectively). Subsequent PARAFAC analysis demonstrated the extraction of the equilibrium concentration profiles for the TC–Al3+, TC–Al3+–DNA and MB probe systems. This information is unobtainable by conventional means of data interpretation. The results indicated that the MB dye interacted with the TC–Al3+–DNA surface complex, presumably via a reaction intermediate, TC–Al3+–DNA–MB, leading to the displacement of the TC–Al3+ by the incoming MB dye probe.

Enhancement of DNA repair using topical T4 endonuclease V does not inhibit melanoma formation in Cdk4R24C/R24C/Tyr-NrasQ61K mice following neonatal UVR

To further investigate the use of DNA repair-enhancing agents for skin cancer prevention, we treated Cdk4R24C/R24C/NrasQ61K mice topically with the T4 endonuclease V DNA repair enzyme (known as Dimericine) immediately prior to neonatal ultraviolet radiation (UVR) exposure, which has a powerful effect in exacerbating melanoma development in the mouse model. Dimericine has been shown to reduce the incidence of basal-cell and squamous cell carcinoma. Unexpectedly, we saw no difference in penetrance or age of onset of melanoma after neonatal UVR between Dimericine-treated and control animals, although the drug reduced DNA damage and cellular proliferation in the skin. Interestingly, epidermal melanocytes removed cyclobutane pyrimidine dimers (CPDs) more efficiently than surrounding keratinocytes. Our study indicates that neonatal UVR-initiated melanomas may be driven by mechanisms other than solely that of a large CPD load and/or their inefficient repair. This is further suggestive of different mechanisms by which UVR may enhance the transformation of keratinocytes and melanocytes.

Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research

Cell proliferation is a critical and frequently studied feature of molecular biology in cancer research. Therefore, various assays are available using different strategies to measure cell proliferation. Metabolic assays such as AlamarBlue, WST-1, and MTT, which were originally developed to determine cell toxicity, are being used to assess cell numbers. Additionally, proliferative activity can be determined by quantification of DNA content using fluorophores, such as CyQuant and PicoGreen. Referring to data published in high ranking cancer journals, 945 publications applied these assays over the past 14 years to examine the proliferative behaviour of diverse cell types. Within this study, mainly metabolic assays were used to quantify changes in cell growth yet these assays may not accurately reflect cellular proliferation rates due to a miscorrelation of metabolic activity and cell number. Testing this hypothesis, we compared metabolic activity of different cell types, human cancer cells and primary cells, over a time period of 4 days using AlamarBlue and fluorometric assays CyQuant and PicoGreen to determine their DNA content. Our results show certain discrepancies in terms of over-estimation of cell proliferation with respect to the metabolic assay in comparison to DNA binding fluorophores.

Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors

Recent studies have shown that human papillomavirus (HPV) DNA can be found in circulating blood, including peripheral blood mononuclear cells (PBMCs), sera, plasma, and arterial cord blood. In light of these findings, DNA extracted from PBMCs from healthy blood donors were examined in order to determine how common HPV DNA is in blood of healthy individuals. Blood samples were collected from 180 healthy male blood donors (18-76 years old) through the Australian Red Cross Blood Services. Genomic DNA was extracted and specimens were tested for HPV DNA by PCR using a broad range primer pair. Positive samples were HPV-type determined by cloning and sequencing. HPV DNA was found in 8.3% (15/180) of the blood donors. A wide variety of different HPV types were isolated from the PBMCs; belonging to the cutaneous beta and gamma papillomavirus genera and mucosal alpha papillomaviruses. High-risk HPV types that are linked to cancer development were detected in 1.7% (3/180) of the PBMCs. Blood was also collected from a healthy HPV-positive 44-year-old male on four different occasions in order to determine which blood cell fractions harbor HPV. PBMCs treated with trypsin were negative for HPV, while non-trypsinized PBMCs were HPV-positive. This suggests that the HPV in blood is attached to the outside of blood cells via a protein-containing moiety. HPV was also isolated in the B cells, dendritic cells, NK cells, and neutrophils. To conclude, HPV present in PBMCs could represent a reservoir of virus and a potential new route of transmission.

Receptor-DNA interactions: EMSA and footprinting

Defining the precise promoter DNA sequence motifs where nuclear receptors and other transcription factors bind is an essential prerequisite for understanding how these proteins modulate the expression of their specific target genes. The purpose of this chapter is to provide the reader with a detailed guide with respect to the materials and the key methods required to perform this type of DNA-binding analysis. Irrespective of whether starting with purified DNA-binding proteins or somewhat crude cellular extracts, the tried-and-true procedures described here will enable one to accurately access the capacity of specific proteins to bind to DNA as well as to determine the exact sequences and DNA contact nucleotides involved. For illustrative purposes, we primarily have used the interaction of the androgen receptor with the rat probasin proximal promoter as our model system.